Literature DB >> 29078947

Vaginal Birth After Cesarean Trends: Which Way Is the Pendulum Swinging?

James Sargent1, Aaron B Caughey2.   

Abstract

The cesarean delivery rate has plateaued at 32%; concurrently, after peaking in the mid-1990s, trial of labor after cesarean (TOLAC) rates have declined. Less than 25% of women with a prior cesarean delivery attempt a future TOLAC. This decreasing trend in TOLAC is caused by inadequate resource availability, malpractice concerns, and lack of knowledge in patients and providers regarding the perceived risks and benefits. This article outlines the factors influencing recent vaginal birth after cesarean trends in addition to reviewing the maternal and neonatal outcomes associated with TOLAC, specifically in high-risk populations.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cesarean; Labor and delivery; TOLAC; VBAC

Mesh:

Year:  2017        PMID: 29078947     DOI: 10.1016/j.ogc.2017.08.006

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  3 in total

Review 1.  Women's Perceptions of Barriers and Facilitators to Vaginal Birth After Cesarean in the United States: An Integrative Review.

Authors:  Bridget Basile Ibrahim; Holly Powell Kennedy; Robin Whittemore
Journal:  J Midwifery Womens Health       Date:  2020-04-30       Impact factor: 2.388

2.  Outcomes of trial of labor after cesarean birth by provider type in low-risk women.

Authors:  Matthew S Fore; Amanda A Allshouse; Nicole S Carlson; K Joseph Hurt
Journal:  Birth       Date:  2019-12-10       Impact factor: 3.689

3.  Cesarean birth in the Global Network for Women's and Children's Health Research: trends in utilization, risk factors, and subgroups with high cesarean birth rates.

Authors:  Margo S Harrison; Ana L Garces; Shivaprasad S Goudar; Sarah Saleem; Janet L Moore; Fabian Esamai; Archana B Patel; Elwyn Chomba; Carl L Bose; Edward A Liechty; Nancy F Krebs; Richard J Derman; Patricia L Hibberd; Waldemar A Carlo; Antoinette Tshefu; Marion Koso-Thomas; Elizabeth M McClure; Robert L Goldenberg
Journal:  Reprod Health       Date:  2020-12-17       Impact factor: 3.223

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.